Now playing Next Markets Europe's GRANOLAS: How do they perform against the US's Magnificent 7? GRANOLAS is an acronym coined by Goldman Sachs during the first European lockdown in 2020, representing the largest European companies by market cap at that time. 26/06/2024
Now playing Next Health news This French start-up wants to use AI to get drugs to market faster French start-up Yseop has partnered with Amazon Web Services (AWS) to use generative AI to assist pharma companies with clinical trials and drug approval. 24/05/2024
Now playing Next Markets Who are the GRANOLAS? A look at Europe's 'Magnificent Eleven' stocks Goldman Sachs shines a light on Europe's market leaders, dubbed the 'GRANOLAS', echoing the 'Magnificent Seven' of Wall Street. With a combined market cap exceeding €2.6 trillion, these firms continue to dominate sectors and outperform in European markets. 13/02/2024
Now playing Next The Big Question Novartis doctor on Big Pharma’s battle against climate change If the healthcare industry was a country, it would be the fifth largest polluter on Earth. 01/02/2024
Now playing Next Business Kellogg’s split: A common business strategy? American company Kellogg’s split up into two separate companies earlier in October. Demergers constitute a rather common business strategy. 07/10/2023
Now playing Next Health news Europe's energy crisis could cut production of cheap medicines Some generic medicines may be discontinued, drugmakers warn - as soaring energy bills squeeze their margins. 29/09/2022
Now playing Next Health news Can AI boost drug discovery? We're one big step closer The French-American unicorn Owkin has shown its machine learning tool can get fiercely competitive drugmakers to share research data while protecting their secrets. 20/07/2022
Now playing Next Europe News MEP Awards: Meet this year's winners for best EU lawmakers The annual ceremony honours lawmakers across the political spectrum for their legislative and political work. 30/06/2022
Now playing Next Partner content We must act now to decarbonise industrial heat power sources Partner content presented by Novartis We are all fully aware of the vital need to transition to low-carbon energy sources in the electricity sector. 09/11/2021
Now playing Next Partner content We need to set bold goals today to ensure a healthier planet tomorrow Partner content presented by Novartis Public health and planetary health are inseparably linked. A healthy environment fuels vibrant human living in the same way a polluted world degrades our air, water, and every resource that feeds life. 08/11/2021
Now playing Next Climate How is the pharmaceutical industry trying to become more green? Ten of the world’s biggest pharmaceutical companies have pledged to improve their energy efficiency. 04/11/2021
Now playing Next Partner content How protecting water can avert future global health crises Partner content presented by Novartis Every way we interact with the planet stems from how we use water. 23/08/2021
Now playing Next Tech News UK baby first to receive a game-changing gene therapy on the NHS Zolgensma is a potentially life-saving therapy for five-month-old baby Arthur Morgan. It’s also one of the world’s most expensive drug. 01/06/2021
Now playing Next Partner content Changes in Europe provide a sustainability blueprint for the world Partner content presented by Novartis As the world slowly begins to climb out of the depths of the pandemic, a new reality has emerged. Nearly two-thirds of the world now believes climate change is a global emergency that requires immediate action toward environmental sustainability. 31/05/2021
Now playing Next World News Drugmaker launches lottery for life-saving gene therapy in babies Swiss drugmaker Novartis has launched an international lottery for its groundbreaking and extremely costly gene therapy Zolgensma, sparking both hope and outrage among patients’ families. 02/01/2020
Now playing Next Hungary Hungarians raise €2m for sick toddler to access world's priciest drug People in Hungary have raised €2m for the family of a toddler with a rare genetic disorder to access the world’s most expensive drug 25/09/2019
Now playing Next Markets Luxury stocks sparkle in tepid European trading as U.S.-China trade talks loom Luxury stocks sparkle in tepid European trading as U.S.-China trade talks loom 30/01/2019